122 related articles for article (PubMed ID: 38180225)
1. Assessing quality of life in horses and ponies with PPID.
Bouquet A
Vet Rec; 2024 Jan; 194(1):41. PubMed ID: 38180225
[No Abstract] [Full Text] [Related]
2. Measurement of cortisol concentration in the tears of horses and ponies with pituitary pars intermedia dysfunction.
Hart KA; Kitchings KM; Kimura S; Norton NA; Myrna KE
Am J Vet Res; 2016 Nov; 77(11):1236-1244. PubMed ID: 27805438
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of plasma ACTH, alpha-melanocyte-stimulating hormone, and insulin concentrations during various photoperiods in clinically normal horses and ponies and those with pituitary pars intermedia dysfunction.
Beech J; Boston RC; McFarlane D; Lindborg S
J Am Vet Med Assoc; 2009 Sep; 235(6):715-22. PubMed ID: 19751169
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004.
Rohrbach BW; Stafford JR; Clermont RS; Reed SM; Schott HC; Andrews FM
J Vet Intern Med; 2012; 26(4):1027-34. PubMed ID: 22524260
[TBL] [Abstract][Full Text] [Related]
5. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
Copas VE; Durham AE
Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.
Beech J; Boston R; Lindborg S
J Vet Intern Med; 2011; 25(6):1431-8. PubMed ID: 22092639
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunofluorescence and chemiluminescence assays for measuring ACTH in equine plasma.
McGilvray TA; Knowles EJ; Harris PA; Menzies-Gow NJ
Equine Vet J; 2020 Sep; 52(5):709-714. PubMed ID: 31955443
[TBL] [Abstract][Full Text] [Related]
8. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
Horn R; Bertin FR
J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
[TBL] [Abstract][Full Text] [Related]
10. The oral glucose test predicts laminitis risk in ponies fed a diet high in nonstructural carbohydrates.
Meier AD; de Laat MA; Reiche DB; Pollitt CC; Walsh DM; McGree JM; Sillence MN
Domest Anim Endocrinol; 2018 Apr; 63():1-9. PubMed ID: 29172109
[TBL] [Abstract][Full Text] [Related]
11. Influence of feeding and other factors on adrenocorticotropin concentration and thyrotropin-releasing hormone stimulation test in horses and ponies.
Drozdzewska K; Winter J; Barton AK; Merle R; Gehlen H
Equine Vet J; 2024 Mar; 56(2):342-351. PubMed ID: 38010866
[TBL] [Abstract][Full Text] [Related]
12. Investigation of breed differences in plasma adrenocorticotropic hormone concentrations among healthy horses and ponies.
Bamford NJ; Stewart AJ; El-Hage CM; Bertin FR; Bailey SR
Vet J; 2023; 296-297():105995. PubMed ID: 37207985
[TBL] [Abstract][Full Text] [Related]
13. Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.
Rendle DI; Litchfield E; Heller J; Hughes KJ
Equine Vet J; 2014 Jan; 46(1):113-7. PubMed ID: 23742059
[TBL] [Abstract][Full Text] [Related]
14. [Nutrition of horses with equine pituitary pars intermedia dysfunction ("Cushing's syndrome") treated with pergolid - A field study].
Kienzle E; Bockhorni T
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Aug; 46(4):249-256. PubMed ID: 30142655
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of age and pituitary pars intermedia dysfunction on corneal sensitivity in horses.
Miller C; Utter ML; Beech J
Am J Vet Res; 2013 Jul; 74(7):1030-5. PubMed ID: 23802675
[TBL] [Abstract][Full Text] [Related]
16. Relationships of inflamm-aging with circulating nutrient levels, body composition, age, and pituitary pars intermedia dysfunction in a senior horse population.
Siard-Altman MH; Harris PA; Moffett-Krotky AD; Ireland JL; Betancourt A; Barker VD; McMurry KE; Reedy SE; Adams AA
Vet Immunol Immunopathol; 2020 Mar; 221():110013. PubMed ID: 32058159
[TBL] [Abstract][Full Text] [Related]
17. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
Knowles EJ; Menzies-Gow NJ; Mair TS
Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors.
Ireland JL; McGowan CM
Vet J; 2018 May; 235():22-33. PubMed ID: 29704935
[TBL] [Abstract][Full Text] [Related]
19. Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction.
McFarlane D; Holbrook TC
J Vet Intern Med; 2008; 22(2):436-42. PubMed ID: 18371032
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
Donaldson MT; Jorgensen AJ; Beech J
J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
